The 36-month beta value for NYXH is at 1.60. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NYXH is 9.44M, and currently, shorts hold a 2.79% of that float. The average trading volume for NYXH on May 24, 2024 was 43.03K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
NYXH) stock’s latest price update
The stock price of Nyxoah SA (NASDAQ: NYXH) has dropped by -17.69 compared to previous close of 10.12. Despite this, the company has seen a fall of -18.89% in its stock price over the last five trading days. globenewswire.com reported 2024-05-23 that REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Pricing of Offering Mont-Saint-Guibert, Belgium – May 23, 2024, 3:50 pm CET / 9:50 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), announced today the pricing of an underwritten public offering in the United States, which includes shares sold in a private offering to certain qualified or institutional investors outside the United States, including within the European Union, of 5,374,755 of its ordinary shares at an offering price of $9.25 (EUR 8.54) per share, before underwriting discounts and commissions. All of the ordinary shares are being offered by Nyxoah and there are no selling stockholders participating in the offering.
NYXH’s Market Performance
Nyxoah SA (NYXH) has seen a -18.89% fall in stock performance for the week, with a -20.52% decline in the past month and a -49.64% plunge in the past quarter. The volatility ratio for the week is 11.55%, and the volatility levels for the past 30 days are at 11.25% for NYXH. The simple moving average for the past 20 days is -15.24% for NYXH’s stock, with a -3.88% simple moving average for the past 200 days.
Analysts’ Opinion of NYXH
Oppenheimer gave a rating of “Outperform” to NYXH, setting the target price at $30 in the report published on April 21st of the previous year.
NYXH Trading at -28.22% from the 50-Day Moving Average
After a stumble in the market that brought NYXH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -58.35% of loss for the given period.
Volatility was left at 11.25%, however, over the last 30 days, the volatility rate increased by 11.55%, as shares sank -21.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -52.40% lower at present.
During the last 5 trading sessions, NYXH fell by -18.89%, which changed the moving average for the period of 200-days by +5.64% in comparison to the 20-day moving average, which settled at $9.71. In addition, Nyxoah SA saw 79.53% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NYXH
Current profitability levels for the company are sitting at:
- -9.05 for the present operating margin
- 0.36 for the gross margin
The net margin for Nyxoah SA stands at -8.43. The total capital return value is set at -0.47. Equity return is now at value -40.68, with -32.75 for asset returns.
Based on Nyxoah SA (NYXH), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -4.81. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is -89.04.
Currently, EBITDA for the company is -43.29 million with net debt to EBITDA at 0.22. When we switch over and look at the enterprise to sales, we see a ratio of 41.25. The receivables turnover for the company is 0.84for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.99.
Conclusion
In conclusion, Nyxoah SA (NYXH) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
